Munetoshi Sugiura

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Combination Therapy

Venous Thromboembolism

Transforming Growth Factor

Top Venues

Journal of pharmaceutical health care and sciences

Evidence-based complementary and alternative medicine : eCAM

Drugs - real world outcomes

This page only lists publications with an associated author ORCID identifier.

Publications

Hiroshi Magara, Takuaki Tani, Shinobu Imai, Anna Kiyomi, Kiyohide Fushimi, Munetoshi Sugiura
Fasudil hydrochloride and ozagrel sodium combination therapy for patients with aneurysmal subarachnoid hemorrhage: a cross-sectional study using a nationwide inpatient database. Journal of pharmaceutical health care and sciences 10 (1) (2024)
Hiroshi Magara, Takuaki Tani, Shinobu Imai, Anna Kiyomi, Kiyohide Fushimi, Munetoshi Sugiura
Fasudil hydrochloride and ozagrel sodium combination therapy for patients with aneurysmal subarachnoid hemorrhage: a cross-sectional study using a nationwide inpatient database. Journal of pharmaceutical health care and sciences 10 (1) (2024)
Hiroyuki Hashimoto, Shinobu Imai, Ryoka Yamashita, Anna Kiyomi, Munetoshi Sugiura
Association of Antipsychotic Drugs with the Risk of Recurrent Venous Thromboembolism: A Retrospective Study of Data from a Japanese Inpatient Database. Drugs - real world outcomes (2023)
Kyosuke Yamazaki, Anna Kiyomi, Shinobu Imai, Munetoshi Sugiura
Saireito (114) Increases IC50 and Changes T-Cell Phenotype When Used in Combination with Prednisolone Therapy in Human Peripheral Blood Mononuclear Cells. Evidence-based complementary and alternative medicine : eCAM 2022 (2022)
Anna Kiyomi, Ayaka Matsuda, Moeko Nara, Kyosuke Yamazaki, Shinobu Imai, Munetoshi Sugiura
Immunological Differences in Human Peripheral Blood Mononuclear Cells Treated with Traditional Japanese Herbal Medicines Hochuekkito, Juzentaihoto, and Ninjin'yoeito from Different Pharmaceutical Companies. Evidence-based complementary and alternative medicine : eCAM 2021 (2021)